Trial Profile
A study to investigate the effect of fibrogenesis biomarkers in patients with rheumatoid arthritis treated with methotrexate monotherapy or in combination of either tocilizumab, tofacitinib or adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate (Primary) ; Tocilizumab (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- 10 Feb 2016 New trial record